Pediatric Heart Network
11
0
1
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
9.1%
1 terminated/withdrawn out of 11 trials
90.0%
+3.5% vs industry average
27%
3 trials in Phase 3/4
44%
4 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
Role: collaborator
Pharmacokinetic/Pharmacodynamic Study of Udenafil in Adolescents
Role: collaborator
Comparison of Two Types of Shunts in Infants With Single Ventricle Defect Undergoing Staged Reconstruction--Pediatric Heart Network
Role: collaborator
A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
Role: collaborator
SVRII Family Factors Study
Role: collaborator
MyHeartBaby: An Initial Evaluation of the MyHeartBaby Psychosocial Telemedicine Program
Role: collaborator
Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation
Role: collaborator
Relationship Between Functional Health Status and Ventricular Performance After Fontan--Pediatric Heart Network
Role: collaborator
Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart Network
Role: collaborator
Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network
Role: collaborator
Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network
Role: collaborator
All 11 trials loaded